Estimaciones de analistas de Wall Street para Retractable Technologies, Inc. (RVP): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-08-14 | $0.09 | ||
| 2026-05-15 | $-0.14 | ||
| 2026-03-27 | $-0.08 | ||
| 2025-11-14 | $0.01 | ||
| 2025-08-14 | $-0.12 | ||
| 2025-05-15 | $-0.11 | ||
| 2025-03-28 | $0.13 | ||
| 2024-11-14 | $-0.07 |
Ratios de valoración
| Precio / Valor contable | 0.28 |
| EV / EBITDA | 4.20 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $29.8M | $34.5M | $33.3M | $41.8M | $81.9M | $188.4M | $94.8M | $43.6M | $33.0M | $38.3M |
| Coste de Ventas | $19.5M | $24.5M | $23.1M | $27.7M | $44.9M | $93.0M | $66.6M | $34.5M | $34.1M | $38.2M |
| Beneficio Bruto | $10.3M | $10.0M | $10.2M | $14.1M | $37.0M | $95.4M | $28.3M | $9.1M | -$1.0M | $47046 |
| I+D | $571842 | $740567 | $621365 | $516095 | $574527 | $901381 | $525727 | $581172 | $673944 | $675567 |
| Generales y Administrativos | $12.8M | $13.0M | $11.2M | $10.7M | $12.4M | $21.9M | $28.6M | $20.0M | $19.4M | $19.6M |
| Gastos Operativos | $13.4M | $13.8M | $11.8M | $11.2M | $12.9M | $22.8M | $29.1M | $20.6M | $20.1M | $20.3M |
| Beneficio Operativo | -$3.5M | -$3.8M | -$1.3M | $3.0M | $24.1M | $72.6M | -$852976 | -$11.5M | -$21.1M | -$20.2M |
| EBITDA | -$2.6M | -$2.9M | -$289257 | $4.2M | $27.2M | $76.4M | $9.9M | -$1.2M | $4.2M | -$4.4M |
| Gastos por Intereses | $213295 | $210761 | $177190 | $166897 | $260264 | $227183 | $170651 | $152166 | $122500 | $87904 |
| Beneficio Antes de Impuestos | -$3.7M | -$3.9M | -$1.4M | $3.2M | $26.1M | $75.0M | $5.2M | -$8.9M | -$3.5M | -$12.3M |
| Impuestos | $1132 | -$187608 | -$13318 | $7875 | $1.9M | $18.9M | $83870 | -$1.9M | $8.4M | $291293 |
| Beneficio Neto | -$3.7M | -$3.7M | -$1.3M | $3.1M | $24.2M | $56.1M | $5.1M | -$7.0M | -$11.9M | -$12.6M |
| BPA | $-0.13 | $-0.12 | $-0.04 | $0.07 | $0.80 | $1.65 | $0.15 | $-0.24 | $-0.40 | $-0.43 |
| BPA Diluido | $-0.13 | $-0.12 | $-0.04 | $0.07 | $0.80 | $1.63 | $0.15 | $-0.24 | $-0.40 | $-0.43 |
| Acciones en Circulación (Diluidas) | $29.4M | $32.0M | $32.7M | $32.7M | $33.3M | $34.2M | $33.0M | $29.9M | $29.9M | $29.9M |
Precio
| Precio | $0.68 |
| Capitalización | $20M |
| Bolsa | AMEX |
| País | US |
Empresas relacionadas: CLGN · FEMY · HBIO · NRSN · NRXS · NXGL · NXL
Explorar sector: Healthcare · Medical - Instruments & Supplies
Más secciones de RVP: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones